Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -3.31%195.1B | -6.65%795.27B | -7.92%198.75B | -10.07%197.83B | -3.74%196.92B | -4.63%201.77B | 16.23%851.96B | 11.98%215.84B | 16.54%219.99B | 23.09%204.57B |
Cost of revenue | -6.41%127.34B | -1.35%519.43B | -6.45%129.98B | -6.71%123.7B | 3.45%129.69B | 4.95%136.06B | 20.39%526.55B | 17.79%138.94B | 16.30%132.6B | 27.98%125.36B |
Gross profit | 3.12%67.76B | -15.23%275.84B | -10.57%68.77B | -15.17%74.13B | -15.11%67.23B | -19.78%65.71B | 10.07%325.41B | 2.81%76.91B | 16.91%87.38B | 16.06%79.2B |
Operating expense | 5.09%34.8B | -0.09%133.93B | 4.81%34.28B | -4.74%33.24B | -2.91%33.29B | 2.97%33.12B | 19.27%134.05B | 3.80%32.7B | 21.51%34.89B | 29.93%34.29B |
Operating profit | 1.12%32.96B | -25.84%141.92B | -21.96%34.5B | -22.10%40.89B | -24.43%33.94B | -34.49%32.59B | 4.43%191.36B | 2.09%44.2B | 14.04%52.49B | 7.32%44.91B |
Net non-operating interest income (expenses) | 68.11%1.63B | 18.46%4.55B | 30.90%1.27B | 0.88%1.15B | 25.43%1.16B | 20.22%969M | 86.86%3.84B | 56.36%971M | 115.78%1.14B | 107.61%928M |
Non-operating interest income | 68.11%1.63B | 18.46%4.55B | 30.90%1.27B | 0.88%1.15B | 25.43%1.16B | 20.22%969M | 86.86%3.84B | 56.36%971M | 115.78%1.14B | 107.61%928M |
Net investment income | -1.47%269M | 18.32%2.27B | 5.08%207M | 38.43%335M | 19.80%1.46B | 3.02%273M | 68.95%1.92B | 3.68%197M | 9.01%242M | 130.93%1.22B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | -7.45%6.19B | -14.92%27.54B | -13.87%6.88B | -26.44%6.3B | -4.39%7.67B | -14.20%6.68B | 39.98%32.37B | 17.25%7.99B | 46.00%8.57B | 38.67%8.03B |
Special income (charges) | 59.52%-1.5B | 80.53%-600M | -229.49%-514M | -102.91%-3.69B | -345.88%-3.08B | 26.49%-283M | -14.57%-173M | |||
Less:Other special charges | ---- | -39.45%1.5B | -67.69%600M | ---- | ---- | 229.49%514M | 35.66%2.47B | 168.74%1.86B | -26.49%283M | 14.57%173M |
Less:Write off | ---- | --0 | ---- | ---- | ---- | ---- | --1.22B | ---- | ---- | ---- |
Other non-operating income (expenses) | -94.79%87M | 61.88%6.97B | 114.32%4.36B | 1,119.00%1.22B | -124.98%-274M | 55.11%1.67B | -16.88%4.31B | 20.02%2.03B | -93.14%100M | -21.75%1.1B |
Income before tax | -1.31%41.13B | -21.01%181.76B | -10.90%46.61B | -21.29%48.99B | -20.59%44.48B | -30.00%41.68B | 8.07%230.1B | 0.75%52.31B | 15.89%62.25B | 12.32%56.01B |
Income tax | 5.45%11.35B | -17.66%46.27B | 2.83%11.21B | -11.63%13.96B | -20.88%10.34B | -34.48%10.76B | 3.24%56.19B | -25.59%10.9B | 23.13%15.79B | 21.87%13.07B |
Net income | -3.67%29.78B | -22.10%135.49B | -14.51%35.4B | -24.58%35.04B | -20.50%34.13B | -28.30%30.91B | 9.73%173.91B | 11.09%41.41B | 13.62%46.46B | 9.70%42.94B |
Net income continuous operations | -3.67%29.78B | -22.10%135.49B | -14.51%35.4B | -24.58%35.04B | -20.50%34.13B | -28.30%30.91B | 9.73%173.91B | 11.09%41.41B | 13.62%46.46B | 9.70%42.94B |
Noncontrolling interests | 65.87%977M | -30.03%2.33B | -7.29%585M | -26.57%633M | -38.27%521M | -40.51%589M | 3.42%3.33B | -18.58%631M | 12.83%862M | 7.65%844M |
Net income attributable to the company | -5.02%28.8B | -21.94%133.16B | -14.62%34.82B | -24.54%34.4B | -20.14%33.61B | -28.01%30.32B | 9.86%170.59B | 11.72%40.78B | 13.63%45.59B | 9.75%42.09B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -5.02%28.8B | -21.94%133.16B | -14.62%34.82B | -24.54%34.4B | -20.14%33.61B | -28.01%30.32B | 9.86%170.59B | 11.72%40.78B | 13.63%45.59B | 9.75%42.09B |
Gross dividend payment | ||||||||||
Basic earnings per share | -4.27%30.46 | -21.46%140.23 | -14.02%36.8 | -23.92%36.33 | -19.82%35.28 | -27.68%31.82 | 10.28%178.55 | 12.45%42.8 | 14.14%47.75 | 10.02%44 |
Diluted earnings per share | -4.27%30.46 | -21.46%140.23 | -14.01%36.8 | -23.92%36.33 | -19.82%35.28 | -27.68%31.82 | 10.28%178.55 | 12.45%42.7948 | 14.14%47.75 | 10.03%44 |
Dividend per share | 0 | -21.46%84.14 | -19.23%43.88 | 0 | -23.76%40.26 | 0 | 10.29%107.132 | 13.33%54.328 | 0 | 7.32%52.804 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |